Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.59 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.59 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.59 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.59 |
| ▸ | GSK3B | P49841 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16203497 | 0.94 | ALDH1A1 (0.71) | ALDH1A1KDM4EUSP2HDAC1HDAC8 | |
| SCHEMBL6665311 | 0.82 | HDAC1 (0.53) | ALDH1A1KDM4EUSP2HDAC1HDAC8 | |
| SCHEMBL28657721 | 0.81 | ALDH1A1 (0.63) | ALDH1A1KDM4EUSP2RAB9ALMNA | |
| SCHEMBL4734470 | 0.80 | GSR (0.62) | HDAC1HDAC8HDAC3HDAC4HDAC7 | |
| SCHEMBL11754117 | 0.80 | ALDH1A1 (0.64) | ALDH1A1KDM4EHDAC1HDAC8HDAC3 | |
| SCHEMBL23554948 | 0.79 | ALDH1A1 (0.61) | ALDH1A1KDM4EUSP2GSK3BSMN1; SMN2 | |
| SCHEMBL5720470 | 0.79 | ALDH1A1 (0.61) | ALDH1A1KDM4EUSP2RAB9ASMN1; SMN2 | |
| SCHEMBL3377472 | 0.79 | ALDH1A1 (0.61) | ALDH1A1KDM4EUSP2SMN1; SMN2L3MBTL1 | |
| SCHEMBL8132385 | 0.79 | ALDH1A1 (0.61) | ALDH1A1KDM4EUSP2GSK3BRAB9A | |
| SCHEMBL3377479 | 0.79 | ALDH1A1 (0.61) | ALDH1A1KDM4EUSP2RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4048034-A | Photopolymerization using an alpha-aminoacetophenone | UOP INC. (US) | 1977-09-13 | — | — | US | claimed |
| US-7879808-B2 | potent activity against resistant pneumococci; for treating domestic fowl | MEIJI SEIKA KAISHA, LTD. (JP) | 2011-02-01 | — | — | US | disclosed |
| US-20100210570-A1 | LINCOMYCIN DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT | MEIJI SEIKA KAISHA LTD. (JP) | 2010-08-19 | — | — | US | disclosed |
| EP-2151447-A1 | LINCOMYCIN DERIVATIVES AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | Meiji Seika Kaisha Ltd. (JP) | 2010-02-10 | — | — | EP | disclosed |
| US-4048034-A | Photopolymerization using an alpha-aminoacetophenone | UOP INC. (US) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210570-A1 | LINCOMYCIN DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT | LAS1L, LCLAT1, LYPLA1 | ALDH1A1 3224/4885KDM4E 3818/4885USP2 4312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.